Koppel Adam
SEC-identified person · CIK 1578965 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kailera Therapeutics, Inc. KLRA | Director | filed 2026 - 2026 |
| Foghorn Therapeutics Inc. FHTX | Director | filed 2020 - 2024 |
| Cerevel Therapeutics Holdings, Inc. CERF | Director | filed 2020 - 2024 |
| Solid Biosciences, LLC SLDB | Director | filed 2018 - 2024 |
| Aptinyx Inc. APTX | Director | filed 2018 - 2022 |
| Dicerna Pharmaceuticals Inc DRNA | Director | filed 2017 - 2021 |
| Springworks Therapeutics, Inc. [SWTX | Officer | filed 2019 - 2021 |
| Rapid Micro Biosystems, INC. [RPID] | Officer | filed 2021 - 2021 |
| Bcls Acquisition Corp. BLSA | Director | filed 2020 - 2020 |
| Annexon, Inc. ANNX | Officer | filed 2020 - 2020 |
| Arcutis Biotherapeutics, Inc. ARQT | Officer | filed 2020 - 2020 |
| Replimune Group, Inc. REPL | Director | filed 2018 - 2018 |
| Trevena INC TRVN | Director | filed 2014 - 2018 |
| Marinus Pharmaceuticals, INC. NASDAQMRNS | Officer | filed 2017 - 2017 |
| PTC Therapeutics, INC. PTCT | Director | filed 2013 - 2017 |
| Biogen INC. BIIB | SVP, Chief Strategy Officer | filed 2014 - 2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.